Cellares has inked its first international deal with Bristol Myers Squibb, with the cell therapy manufacturer noting it is going through “tremendous tailwinds” from the Biosecure Act with increased interest from many potential clients. Bristol Myers has reserved…
#bristol #squibb #biosecureact #unlock
Continue reading...